Akston Biosciences: “Akston Biosciences Signs Licensing Agreement with Dechra Pharma for AKS-425c, a Once-a-Week Insulin Therapy for Cats Follows earlier agreement between Akston and Dechra for AKS-321d, a once-a-week insulin therapy for dogs”

Share

Related Posts